Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Vical’s cancer immunotherapy fails in late-stage trial

Allovectin no better than standard chemotherapy

Pharma deals during July 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for July 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Roche - Basel

Roche’s Erivedge authorised in UK

Available for skin cancer patients through Cancer Drugs Fund

- PMLiVE

Malaria vaccine gives “unprecedented” results

Able to protect 12 out of 15 people in phase I trial

- PMLiVE

Isis drops arthritis candidate

ISIS-CRP Rx disappoints in phase II

- PMLiVE

First Scottish base for KnowledgePoint360

Healthcare comms agency sets up office in Glasgow

- PMLiVE

Kite Pharma appoints cancer immunotherapy experts

Ronald Levy, Zelig Eshhar and Inder Verma will offer expert advice to US biotech

- PMLiVE

Understanding the post-digital world

The ubiquity of digital demands that pharmaceutical companies focus more closely than ever on finding out what their customers want

- PMLiVE

Boehringer eyes obesity market

Aims to widen metabolism portfolio beyond diabetes

- PMLiVE

VIDEO: The impact of new technology on healthcare

Mindy Daeschner, director of PSHealth, explains how technology needs to be part of any discussion on the value of treatment

- PMLiVE

Novo says three year wait for Tresiba safety data

Trial will start this year comparing insulin’s cardiovascular safety to that of Lantus

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links